Limitations, agreements, and source contact

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma · Source last updated 2024-12-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

lseymour@ctg.queensu.ca

organization

Canadian Cancer Trials Group

phone

613533600

phone Ext

75544

title

Dr. Lesley Seymour

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice